Cost-effectiveness of Colorectal Cancer Screening Tests: Reply.
APA
Rui M, Wang Y, You JHS (2026). Cost-effectiveness of Colorectal Cancer Screening Tests: Reply.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 35(2), 352-353. https://doi.org/10.1158/1055-9965.EPI-25-1474
MLA
Rui M, et al.. "Cost-effectiveness of Colorectal Cancer Screening Tests: Reply.." Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, vol. 35, no. 2, 2026, pp. 352-353.
PMID
41630584
같은 제1저자의 인용 많은 논문 (5)
- Tumor microenvironment-responsive conformational activation of apoA-I mimetic peptides for targeted cancer therapy.
- H19 enhances pancreatic cancer proliferation and invasion by reducing miR-29c-5p's inhibitory effects on ATF2/ECM1.
- Perioperative immunotherapy for advanced resectable melanoma: a cost-effectiveness analysis.
- pH-responsive polymeric nanoparticles for peptide delivery: Synergistic STING pathway activation enhances tumor immunotherapy.
- The neuronal protein Neurexin directly interacts with the Scribble-Pix complex to stimulate F-actin assembly for synaptic vesicle clustering.